✦ LIBER ✦

Long-Term Versus Short-Term Clopidogrel Therapy in Patients Undergoing Coronary Stenting (from the Randomized Argentine Clopidogrel Stent [RACS] Trial)

✍ Scribed by Víctor Bernardi; Jorge Szarfer; Gabriel Summay; Oscar Mendiz; Ricardo Sarmiento; Máximo Rodriguez Alemparte; José Gabay; Peter B. Berger

Book ID: 113443433
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 66 KB
Volume: 99
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2006.08.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1 - Randomized comparison of six versus

1 - Randomized comparison of six versus twenty-four months clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all comer patients undergoing percutaneous coronary intervention. Results of the PRODIGY Trial

✍ Vijayakumar Subban 📂 Article 📅 2012 🏛 Cardiological Society of India 🌐 English ⚖ 60 KB

IMPACT OF SHORT- VERSUS LONG-TERM DAPT I

IMPACT OF SHORT- VERSUS LONG-TERM DAPT IN PATIENTS WITH DIABETES MELLITUS UNDERGOING PERCUTANEOUS INTERVENTION WITH ENDEAVOR ZOTAROLIMUS-ELUTING STENTS – A SUBANALYSIS OF THE LARGE, PROSPECTIVE, RANDOMIZED, MULTICENTER OPTIMIZE TRIAL

✍ Feres, Fausto; Costa, Ricardo; Bhatt, Deepak; De Paula, Joao; Botelho, Roberto; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Randomized comparison of 6- versus 24-mo

Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)

✍ Marco Valgimigli; Gianluca Campo; Gianfranco Percoco; Monia Monti; Fabrizio Ferr 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 465 KB

LONG-TERM OUTCOMES OF BIODEGRADABLE POLY

LONG-TERM OUTCOMES OF BIODEGRADABLE POLYMER DRUG-ELUTING STENTS VERSUS DURABLE POLYMER SIROLIMUS-ELUTING STENTS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: A POOLED ANALYSIS OF INDIVIDUAL PATIENT DATA FROM THE ISAR-TEST 4 AND LEADERS RANDOMIZED TRIALS

✍ Giulio G. Stefanini; Robert Byrne; Patrick Serruys; Antoinette de Waha; Bernhard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 105 KB

TCT-353 Long-Term Outcomes of Biodegrada

TCT-353 Long-Term Outcomes of Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents in Patients with Diabetes: A Pooled Analysis of Individual Patient Data from the ISAR-TEST 4 and LEADERS Randomized Trials

✍ Lamin King; Antoinette de Waha; Lamin King; Robert Byrne; Salvatore Cassese; Adn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Long-Term Clinical and Economic Analysis

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)

✍ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri 📂 Article 📅 2009 🏛 American College of Cardiology 🌐 English ⚖ 364 KB